61 related articles for article (PubMed ID: 1651897)
21. Hepatic extraction of the aminoterminal propeptide of type III procollagen before and after bile duct ligation in pigs.
Bentsen KD; Henriksen JH; Boesby S; Jensen LT; Hørslev-Petersen K; Lorenzen I
Liver; 1991 Oct; 11(5):310-5. PubMed ID: 1961091
[TBL] [Abstract][Full Text] [Related]
22. Aminoterminal propeptide of type III procollagen in the follow-up of patients with abdominal aortic aneurysms.
Satta J; Haukipuro K; Kairaluoma MI; Juvonen T
J Vasc Surg; 1997 May; 25(5):909-15. PubMed ID: 9152320
[TBL] [Abstract][Full Text] [Related]
23. Aminoterminal propeptide of type III procollagen: a marker of disease activity in schistosomal patients.
Fayol V; Hassanein HI; el-Badrawy N; Ville G; Hartmann DJ
Eur J Clin Chem Clin Biochem; 1991 Nov; 29(11):737-41. PubMed ID: 1782280
[TBL] [Abstract][Full Text] [Related]
24. [Cushing's syndrome with marked osteoporosis].
Ogawa M; Saito T; Tsutsui K; Kaneko K; Ishikawa S
Horumon To Rinsho; 1983 Sep; 31(9):853-6. PubMed ID: 6315277
[No Abstract] [Full Text] [Related]
25. Collagen metabolism in gynecologic patients: changes in the concentration of the aminoterminal propeptide of type III procollagen in serum.
Puistola U; Risteli L; Risteli J; Kauppila A
Am J Obstet Gynecol; 1990 Oct; 163(4 Pt 1):1276-81. PubMed ID: 2220941
[TBL] [Abstract][Full Text] [Related]
26. Aminoterminal propeptide of type III procollagen in ovarian cancer. A review.
Risteli L; Risteli J; Puistola U; Tomás C; Zhu GG; Kauppila A
Acta Obstet Gynecol Scand Suppl; 1992; 155():99-103. PubMed ID: 1502898
[TBL] [Abstract][Full Text] [Related]
27. Plasma endothelin and the aminoterminal propeptide of type III procollagen (PIIINP) in systemic sclerosis.
Zachariae H; Heickendorff L; Bjerring P; Halkier-Sørensen L; Søndergaard K
Acta Derm Venereol; 1994 Sep; 74(5):368-70. PubMed ID: 7817674
[TBL] [Abstract][Full Text] [Related]
28. [Development of polycythemia to myelofibrosis. Monitoring by the assay of the procollagen III amino-propeptide].
Arrago JP; Poirier O; Najean Y
Presse Med; 1984 Nov; 13(40):2429-32. PubMed ID: 6239221
[TBL] [Abstract][Full Text] [Related]
29. Osteocalcin levels in Cushing's disease before and after treatment.
Sartorio A; Ambrosi B; Colombo P; Morabito F; Faglia G
Horm Metab Res; 1988 Jan; 20(1):70. PubMed ID: 3259531
[No Abstract] [Full Text] [Related]
30. Skin scoring in systemic sclerosis: a modification--relations to subtypes and the aminoterminal propeptide of type III procollagen (PIIINP).
Zachariae H; Bjerring P; Halkier-Sørensen L; Heickendorff L; Søndergaard K
Acta Derm Venereol; 1994 Nov; 74(6):444-6. PubMed ID: 7701875
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of the antigens related to the aminoterminal propeptide of type III procollagen in human serum.
Niemelä O; Risteli L; Sotaniemi EA; Risteli J
Clin Chim Acta; 1982 Sep; 124(1):39-44. PubMed ID: 7127838
[TBL] [Abstract][Full Text] [Related]
32. Primary fibromyalgia: clinical parameters in relation to serum procollagen type III aminoterminal peptide.
Jacobsen S; Jensen LT; Foldager M; Danneskiold-Samsøe B
Br J Rheumatol; 1990 Jun; 29(3):174-7. PubMed ID: 2357497
[TBL] [Abstract][Full Text] [Related]
33. Serum interleukin-6 level in patients with systemic sclerosis: lack of correlation with aminoterminal propeptide of type III procollagen.
Kucharz EJ; Jonderko G; Rubisz-Brzezinska J; Brzezinska-Wcisło L
Clin Rheumatol; 1995 May; 14(3):380-1. PubMed ID: 7641522
[No Abstract] [Full Text] [Related]
34. The effect of external fixator on bone metabolism in patients with open fracture of extremities.
Shi Y; Niu F; Liu Z; Teng Y; Jiao J; Xu P; Ma N; Gao B; Liu B; Gao F
Cell Mol Biol (Noisy-le-grand); 2024 Jun; 70(6):61-65. PubMed ID: 38836683
[TBL] [Abstract][Full Text] [Related]
35. Collagen metabolism in normal and complicated pregnancy: changes in the aminoterminal propeptide of type III procollagen in serum.
Risteli L; Puistola U; Hohtari H; Kauppila A; Risteli J
Eur J Clin Invest; 1987 Feb; 17(1):81-6. PubMed ID: 3106054
[TBL] [Abstract][Full Text] [Related]
36. Type III aminoterminal propeptide of procollagen in some haematological malignancies.
Arrago JP; Poirier O; Chomienne C; D'Agay MF; Najean Y
Scand J Haematol; 1986 Mar; 36(3):288-94. PubMed ID: 3704553
[TBL] [Abstract][Full Text] [Related]
37. Serum aminoterminal propeptide of type III procollagen in the management of methotrexate-induced fibrogenesis.
Kürkçüoğlu N; Oz G
J Am Acad Dermatol; 1992 Jul; 27(1):139. PubMed ID: 1619068
[No Abstract] [Full Text] [Related]
38. Serum procollagen type III aminoterminal peptide in primary fibromyalgia (fibrositis syndrome).
Jensen LT; Jacobsen S; Hørsley-Petersen K
Br J Rheumatol; 1988 Dec; 27(6):496. PubMed ID: 3203198
[No Abstract] [Full Text] [Related]
39. Relationship between stages of the estrous cycle and bone cell activity in Thoroughbreds.
Jackson BF; Dyson PK; Hattersley RD; Kelly HR; Pfeiffer DU; Price JS
Am J Vet Res; 2006 Sep; 67(9):1527-32. PubMed ID: 16948596
[TBL] [Abstract][Full Text] [Related]
40. Relationship of procollagen type III propeptide-related antigens in serum to somatic growth in healthy children and patients with growth disorders.
Danne T; Grüters A; Schuppan D; Quantas N; Enders I; Weber B
J Pediatr; 1989 Feb; 114(2):257-60. PubMed ID: 2915284
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
